Skip to main content

Logo 2839 Logo 2839 Pill - brown & yellow capsule/oblong, 22mm

Pill with imprint Logo 2839 Logo 2839 is Brown & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Actavis Pharma, Inc.

Fenofibric acid is used in the treatment of High Cholesterol; Hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo 2839 Logo 2839

Fenofibric acid delayed-release 135 mg Logo 2839 Logo 2839

Fenofibric Acid Delayed-Release

Logo 2839 Logo 2839
135 mg
Brown & Yellow
22.00 mm
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00228-2839 (Discontinued)
Inactive Ingredients
ammonio methacrylate copolymer type A, ammonio methacrylate copolymer type B, hydroxypropyl cellulose (type l), sodium lauryl sulfate, sucrose, corn starch, magnesium silicate, triethyl citrate, gelatin, titanium dioxide, ferric oxide yellow, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, ammonia, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.